The FDA added a warning to the label of esketamine nasal spray (Spravato), noting that long-term cognitive and memory ...

"This data gives patients the option to benefit from esketamine treatment either with or without an antidepressant," said ...

More information: Jennifer Kern Sliwa et al, Effects of esketamine nasal spray on depressive symptom severity in adults with ...

Johnson & Johnson is to press on with filings for its new depression drug, esketamine, despite one of two late-stage studies missing an efficacy target. Ketamine is best known as an anaesthetic ...

Brain and Cognition Discovery Foundation, Toronto, ON, Canada Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Department of Pharmacology & Toxicology, University ...

recently approved esketamine for treatment-resistant depression. However, its rapid and efficacious antidepressant activity is offset by the significant rate of psychotomimetic and dissociative ...

Janssen’s potential depression treatment made from esketamine – a version of the substance notoriously used illegally as a party drug – is to be reviewed by advisers to the FDA at a crunch ...

When Dr. Husseini Manji was developing the first-in-class depression medication Spravato at Johnson & Johnson he encountered plenty of naysayers.

A recent trial compared the efficacy of augmenting first-line depression treatments with quetiapine versus intranasal esketamine and found the esketamine group was 1.54 times more like to achieve ...

Mental health is a vital aspect of overall well-being, especially for students who face unique pressures and challenges. From ...

Our treatment center offers specialty Psychiatry services TMS (transcranial magnetic stimulation) and Spravato (esketamine) for treatment-resistant depression cases. These services also can have ...